Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Amortization of Intangible Assets

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Amortization of Intangible Assets of $47.20 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2022-02-28

  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for the quarter ending 2016-06-30 was $2.70M, a 350.00% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for the quarter ending 2016-03-31 was $2.50M, a 316.67% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for the quarter ending 2015-12-31 was $600.00K, a 0.00% change year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for the quarter ending 2015-09-30 was $600.00K, a 0.00% change year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for fiscal 2021 was $47.20M, a 101.71% increase from fiscal 2020.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for fiscal 2020 was $23.40M, a 38.46% increase from fiscal 2019.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for fiscal 2019 was $16.90M, a 6.96% increase from fiscal 2018.
  • LIGAND PHARMACEUTICALS INCORPORATED amortization of intangible assets for fiscal 2018 was $15.80M, a 30.58% increase from fiscal 2017.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 9 month as first filedAmortization of Intangible Assets 12 monthAmortization of Intangible Assets 12 month as first filed
2021-12-31$47.20M
10-K · filed 2022-02-28
2020-12-31$23.40M
10-K · filed 2022-02-28
2019-12-31$16.90M
10-K · filed 2022-02-28
2018-12-31$15.80M
10-K · filed 2021-02-24
2017-12-31$12.10M
10-K · filed 2020-02-27
$11.30M
10-K · filed 2018-03-01
2016-12-31$10.60M
10-K · filed 2019-02-28
2016-06-30$2.70M
10-Q · filed 2016-11-14
$5.20M
10-Q · filed 2016-11-14
$5.80M
derived: sum of 3 quarters · filed 2018-03-01
$6.40M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$2.50M
10-Q · filed 2016-11-14
$3.10M
derived: sum of 2 quarters · filed 2018-03-01
$3.70M
derived: sum of 3 quarters · filed 2018-03-01
$4.30M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.20M
derived: sum of 2 quarters · filed 2018-03-01
$1.80M
derived: sum of 3 quarters · filed 2018-03-01
$2.40M
10-K · filed 2018-03-01
2015-09-30$600.00K
10-Q · filed 2015-11-09
$1.20M
derived: sum of 2 quarters · filed 2016-11-14
$1.80M
10-Q · filed 2015-11-09
$2.40M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$600.00K
10-Q · filed 2016-11-14
$1.20M
10-Q · filed 2016-11-14
$1.80M
derived: sum of 3 quarters · filed 2017-02-28
$2.40M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$600.00K
10-Q · filed 2016-11-14
$1.20M
derived: sum of 2 quarters · filed 2017-02-28
$1.80M
derived: sum of 3 quarters · filed 2017-02-28
$2.40M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$1.20M
derived: sum of 2 quarters · filed 2017-02-28
$1.80M
derived: sum of 3 quarters · filed 2017-02-28
$2.40M
10-K · filed 2017-02-28
2014-09-30$600.00K
10-Q · filed 2015-11-09
$1.20M
derived: sum of 2 quarters · filed 2015-11-09
$1.80M
10-Q · filed 2015-11-09
$3.60M
derived: sum of 4 quarters · filed 2016-11-14
2014-06-30$600.00K
10-Q · filed 2015-08-05
$1.20M
10-Q · filed 2015-08-05
$3.00M
derived: sum of 3 quarters · filed 2016-11-14
$3.60M
derived: sum of 4 quarters · filed 2016-11-14
2014-03-31$600.00K
10-Q · filed 2015-05-11
$2.40M
derived: sum of 2 quarters · filed 2016-11-14
$3.00M
derived: sum of 3 quarters · filed 2016-11-14
$3.60M
derived: sum of 4 quarters · filed 2016-11-14
2013-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14
$2.40M
derived: sum of 2 quarters · filed 2016-11-14
$3.00M
derived: sum of 3 quarters · filed 2016-11-14
$2.40M
10-K · filed 2016-11-14
2013-09-30$600.00K
10-Q · filed 2013-11-08
$1.20M
derived: sum of 2 quarters · filed 2013-11-08
$600.00K
10-Q · filed 2013-11-08
$2.40M
derived: sum of 4 quarters · filed 2015-02-23
2013-06-30$600.00K
10-Q · filed 2013-08-01
$600.00K
10-Q · filed 2013-08-01
$1.80M
derived: sum of 3 quarters · filed 2015-02-23
$3.60M
derived: sum of 4 quarters · filed 2015-02-23
2013-03-31$600.00K
10-Q · filed 2014-05-07
$1.20M
derived: sum of 2 quarters · filed 2015-02-23
$3.00M
derived: sum of 3 quarters · filed 2015-02-23
$4.20M
derived: sum of 4 quarters · filed 2015-02-23
2012-12-31$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23
$2.40M
derived: sum of 2 quarters · filed 2015-02-23
$3.60M
derived: sum of 3 quarters · filed 2015-02-23
$2.40M
10-K · filed 2015-02-23
2012-09-30$1.80M
10-Q · filed 2013-11-08
$3.00M
derived: sum of 2 quarters · filed 2013-11-08
$1.80M
10-Q · filed 2013-11-08
$1.70M
10-Q · filed 2012-11-14
$4.00M
derived: sum of 4 quarters · filed 2014-12-12
2012-06-30$1.20M
10-Q · filed 2013-08-01
$1.20M
10-Q · filed 2013-08-01
$2.20M
derived: sum of 3 quarters · filed 2014-12-12
$2.80M
derived: sum of 4 quarters · filed 2014-12-12
2012-03-31$600.00K
10-Q · filed 2013-05-08
$1.00M
derived: sum of 2 quarters · filed 2014-12-12
$1.60M
derived: sum of 3 quarters · filed 2014-12-12
2011-12-31$400.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12
$1.00M
derived: sum of 2 quarters · filed 2014-12-12
$2.30M
10-K/A · filed 2014-12-12
2011-09-30$600.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14
$1.90M
10-Q · filed 2012-11-14
2011-06-30$1.30M
10-Q/A · filed 2012-11-14
2010-12-31$100.00K
10-K · filed 2013-03-14